Tagged: HIV

Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about HIV.

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication management; Medicare Part D as a learning model for pharmacy education—impact 10 years out; New genetic insights into diabetes drug response; Annotating the ‘dark genome’; Epigenetics of ethnicity; New endowed professorships made possible by private support; New Center for Cellular Construction; Major funding for UCSF-Stanford CERSI; 2017 Mary Anne Koda-Kimble Seed Award for Innovation; Welcoming the class of 2020; Three generations at the School of Pharmacy; Developing a curriculum for 2018 and beyond; AFPE honors Frank Szoka as Mentor of the Year; 2016 Chancellor Diversity Awards honor Marcus Ferrone and Peace Chukudi; Eddie Way celebrates 100 years; CPhA Hall of Fame honors Brian Komoto, Phillip Oppenheimer, Wilma Wong; $500M gift to campus from Helen Diller Foundation; UC statement on federal executive order restricting travel and entry.

Fran Aweeka, PharmD, will receive renewed funding for her grant from the National Institutes of Health for evaluating the pharmacology of antimalarial drugs in children in Africa. This is a renewal of her R01 on this important work, and will provide five years of funding for Dr. Aweeka and her colleagues at Yale and in Uganda.